Fredun Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 124 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), EDE (AE) and UZPHARM (UZ). Its GMP standing is certified by NAFDAC (NG). Customs aggregates show $12.2M of exports covering 944 molecules to 12 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Palghar, United Arab Emirates | Not on file |
| Maharashtra State, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 111 | 2 |
| EDE (AE) | 5 | None |
| UZPHARM (UZ) | 5 | None |
| FDA (GH) | 2 | None |
| MINSA (CR) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.1M | 6 |
| 2025 | Not reported | $12.2M | 12 |
| 2024 | Not reported | $10.0M | 11 |
| 2023 | Not reported | $10.0M | 8 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Fredun Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free